IART · Integra Lifesciences Holdings Corp · Documents
$11.92
-0.41 (-3.29%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$958.55M
Shares
77.77M
Volume · Oct 23
506.14K
Avg daily vol (3M)
956.25K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Integra LifeSciences reported third-quarter 2026 revenue of $411.2 million, up 2.3%, and adjusted diluted EPS of $0.59; completed a $2.1 billion refinancing; maintained 2026 revenue guidance of $1.634 billion to $1.654 billion and adjusted EPS guidance of $2.30 to $2.40. | 2026-10-21 | — | |
| 8-K | Integra LifeSciences Holdings Corporation entered a $1.65 billion amended credit agreement and issued $450 million of 9.500% Senior Secured Notes due 2033 on October 19, 2026, using proceeds to repay and terminate its existing term and revolving loans. | 2026-10-19 | — | |
| 8-K | Integra LifeSciences Holdings Corporation priced $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033, and expects the refinancing to raise its effective interest rate near the high end of the previously communicated 100-200 basis points range. | 2026-10-09 | — | |
| 8-K | — | 2026-10-02 | — | |
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 8-K | — | 2026-09-08 | — | |
| 10-Q | — | 2026-07-29 | 2026-06-30 | |
| 8-K | — | 2026-07-29 | — | |
| Investor Event Transcript | — | 2026-06-16 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-12 | 2026-06-30 | |
| 8-K | — | 2026-05-08 | 2026-05-07 | |
| DEFA14A | — | 2026-05-05 | — | |
| 8-K | — | 2026-05-05 | — | |
| 8-K | — | 2026-05-05 | 2026-04-30 | |
| 10-Q | — | 2026-05-05 | 2026-03-31 | |
| 8-K | — | 2026-04-15 | 2026-04-10 | |
| DEF 14A | — | 2026-04-06 | 2025-12-31 | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| S-3ASR | — | 2026-02-26 | — | |
| 8-K | — | 2026-02-26 | — | |
| 8-K | — | 2025-12-12 | 2025-12-11 | |
| 10-Q | — | 2025-10-30 | 2025-09-30 | |
| 8-K | — | 2025-10-30 | — | |
| 8-K | — | 2025-07-31 | — | |
| 10-Q | — | 2025-07-31 | 2025-06-30 | |
| 8-K | — | 2025-06-09 | 2025-06-06 | |
| 8-K | — | 2025-05-13 | 2025-05-09 | |
| 8-K | — | 2025-05-05 | — | |
| 10-Q | — | 2025-05-05 | 2025-03-31 | |
| DEF 14A | — | 2025-04-04 | 2024-12-31 | |
| 8-K | — | 2025-02-25 | — | |
| 10-K | — | 2025-02-25 | 2024-12-31 | |
| 8-K | — | 2025-01-06 | 2024-12-19 | |
| 8-K | — | 2024-12-17 | 2024-12-12 | |
| 10-Q | — | 2024-11-04 | 2024-09-30 | |
| 8-K | — | 2024-11-04 | — | |
| 8-K | — | 2024-11-04 | — | |
| 10-Q | — | 2024-07-29 | 2024-06-30 | |
| 8-K | — | 2024-07-29 | — | |
| 8-K | — | 2024-05-17 | 2024-05-16 | |
| 8-K | — | 2024-05-13 | 2024-05-09 | |
| 10-Q | — | 2024-05-06 | 2024-03-31 | |
| 8-K | — | 2024-05-06 | — | |
| DEF 14A | — | 2024-04-04 | 2023-12-31 | |
| ARS | — | 2024-04-04 | 2023-12-31 | |
| PRE 14A | — | 2024-03-25 | 2023-12-31 |
Showing 1–50 of 140 filings
Key facts
CIK
917520
CUSIP
457985208
13F (30d)
26 filings
26 filers
Visit website
Investor relations